Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Humacyte (HUMA) Revenue (2025)

Humacyte has reported Revenue over the past 1 years, most recently at $467000.0 for Q4 2025.

  • Quarterly results put Revenue at $467000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $2.0 million (changed N/A YoY), and the annual figure for FY2025 was $2.0 million, changed.
  • Revenue for Q4 2025 was $467000.0 at Humacyte, down from $753000.0 in the prior quarter.
  • Over the last five years, Revenue for HUMA hit a ceiling of $753000.0 in Q3 2025 and a floor of $301000.0 in Q2 2025.